Bridging Life Science Automation and Cell & Gene Therapy

Over the past eight years, we have continued to build on our expertise in life science automation, expanding our capabilities to also become a key innovator in cell and gene therapy.
This additional focus on cell and gene therapy complements our core strengths in sample preparation and analytical solutions, enabling us to support the pharmaceutical industry with even greater precision and quality in advancing personalized patient treatments.

Expanding Expertise in Both Life Science Automation and Cell & Gene Therapy

Automation in life sciences remains essential for providing consistent, scalable processes that reduce human error and enable high-throughput analysis. As our expertise in automation evolved, we recognized the opportunity to apply these strengths to the growing field of cell and gene therapy.
Both fields demand the highest levels of precision and reproducibility, and our automation solutions help streamline quality control processes, ensuring therapeutic products meet stringent standards. Meanwhile, our advanced analytics provide deeper insights into treatment efficacy and safety.

Innovating for Pharma’s Evolving Needs

Cell and gene therapies introduce unique requirements that go beyond traditional drug development, especially as treatments become more targeted and personalized. By expanding our automated sample preparation and analytics solutions, we now can support laboratories and production facilities as they transition from research to scalable, pharma-grade solutions.
Our solutions enable the seamless integration of laboratory data into pharmaceutical manufacturing, facilitating more reliable workflows and accelerating the journey from lab to patient.

Our Vision for the Future

We are committed to shaping the future of both life science automation and cell and gene therapy through innovative solutions that bridge these two critical fields. By expanding our expertise, we empower the next generation of therapies, opening up new possibilities in patient care and personalized medicine.

For more information on how we support advancements in life science automation and cell and gene therapy, please contact us directly.